| Date | Title | Description |
| 30.07.2024 | Nine Square Therapeutics Appoints James B. Summers, Ph.D., to Board of Directors and Scientific Advisory Board | Dr. Summers brings more than three decades of drug discovery and pharmaceutical research management experience, including the advancement of more than 20 compounds into clinical development
SAN FRANCISCO--(BUSINESS WIRE)--Nine Square Therap... |
| 12.09.2023 | Nine Square Therapeutics Awarded $4.5 Million Grant from The Michael J. Fox Foundation to Advance Development of Novel Parkin Activators | Nine Square is building a diversified portfolio of first-in-class drug candidates for genetically validated targets along the autophagy/lysosomal pathway
The company has identified compounds that promote Parkin activity to induce clearanc... |
| 12.09.2023 | Nine Square Therapeutics Awarded $4.5 Million Grant from The Michael J. Fox Foundation to Advance Development of Novel Parkin Activators | - |
| 13.09.2022 | Nine Square Therapeutics Appoints John Hood to Board of Directors | SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 /PRNewswire/ -- Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-molecule therapeu... |
| 13.09.2022 | Nine Square Therapeutics Appoints John Hood to Board of Directors | SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 /PRNewswire/ -- Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-molecule therapeu... |
| 11.01.2022 | Nine Square Therapeutics Appoints Robert Paul as CEO | SOUTH SAN FRANCISCO, CA/January 11, 2021 – Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-molecule therapeutics for movement... |
| 11.01.2022 | Nine Square Therapeutics Appoints Robert Paul as CEO | SOUTH SAN FRANCISCO, CA/January 11, 2021 – Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-molecule therapeutics for movement... |
| 11.01.2022 | Nine Square Therapeutics Appoints Robert Paul as CEO | SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 /PRNewswire/ -- Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-molecule therapeut... |
| 19.06.2021 | These 10 AI startups raised the biggest Series A and B rounds of the last 2 years and are poised to boom | Weights & Biases CEO Lukas Biewald; DefinedCrowd CEO Daniela Braga; Otter.ai CEO Sam Liang. Weights & Biases/DefinedCrowd/Otter.ai This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
... |
